ATRION Corporation (ATRI) Peer Comparison

$459.92

$-- (--%)

As on 30-Aug-2024 09:30EDT

Market cap

$809 Mln

Revenue (TTM)

$182 Mln

P/E Ratio

64.5

P/B Ratio

3.4

Div. Yield

1.9 %

Edit

	ATRION Corporation (ATRI)	Asensus Surgical (ASXC)
Market cap ($ Mln)	809	95
Revenue ($ Mln)	182	10
Net Profit ($ Mln)	12.56	-83.80
Net Margin (%)	6.91	-850.75
RoE (%)	5.21	--
Price to Earnings	64.50	--
Price-To-Book	3.39	7.09

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	ATRION Corporation (ATRI)	Asensus Surgical (ASXC)
Operating Revenue	181.60	9.85
Cost of Revenue	123.35	13.19
Gross Profit	62.39	-5.03
Operating Expenses	43.85	67.77
Operating Profit (EBIT)	14.41	-71.11
Other Income	0.00	0.00
Profit before Tax	14.38	-83.44
Provision for Tax	1.82	0.36
Profit after Tax (Net Income)	12.56	-83.80
Minority Interest	0.00	0.00
Consolidated Profit	0.00	0.00

Liabilities ($ Mln)

	ATRION Corporation (ATRI)	Asensus Surgical (ASXC)
Shareholder's Funds	238.87	-11.33
Minority Interest	0.00	0.00
Non-Current Liabilities	3.94	9.91
Current Liabilities	17.54	39.92
Total Liabilities	260.83	60.53

Assets ($ Mln)

	ATRION Corporation (ATRI)	Asensus Surgical (ASXC)
Non-Current Assets	141.09	19.06
Current Assets	119.26	19.44
Total Assets	260.83	60.53
Total Debt*	0.00	20.43
Net Current Assets	101.73	-20.48

Cashflow ($ Mln)

	ATRION Corporation (ATRI)	Asensus Surgical (ASXC)
Cash From Operating Activities	20.01	-63.63
Cash Flow from Investing Activities	--	--
Cash from Financing Activities	-17.04	9.63
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	ATRION Corporation (ATRI)	Asensus Surgical (ASXC)
ROCE (%)	8.04	-108.72
ROE (%)	5.21	-117.89
ROA (%)	4.48	-100.09
EBIT Margin (%)	6.00	-721.18
Net Margin (%)	6.91	-850.75
Cash Profit Margin (%)	0.00	0.00

Growth Ratios

	ATRION Corporation (ATRI)	Asensus Surgical (ASXC)
Revenue Growth (%)	6.00	39.05
EBIT Growth (%)	-55.32	9.04
Net Profit Growth (%)	-53.85	-5.15
EPS Growth (%)	-53.85	4.87
Book Value Growth (%)	-0.85	-116.25

Valuation Ratios

	ATRION Corporation (ATRI)	Asensus Surgical (ASXC)
Price / Earnings	39.03	-1.02
Price / Book Value	3.12	2.39
Dividend Yield (%)	--	--
EV/EBITDA	19.95	-0.87
Market Cap ($ Cr)	--	--

Solvency Ratios

	ATRION Corporation (ATRI)	Asensus Surgical (ASXC)
Debt to Equity	0.00	0.00
Short term debt to equity ratio	0.00	-1.45
Current Ratio	6.80	0.49
Quick Ratio	2.94	0.31
Interest Coverage	118.84	-122.25

Operating Efficiency Ratios

	ATRION Corporation (ATRI)	Asensus Surgical (ASXC)
Debtors to sales (%)	14.62	4.12
Asset Turnover	0.65	0.12
Receivable days	50.67	134.53
Inventory Days	252.92	207.43
Payable days	31.94	100.56
Cash Conversion Cycle	271.65	241.39

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly